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Paenibacillus larvae causes American foulbrood in 
honey bees. We describe P. larvae bacteremia in 5 in-
jection drug users who had self-injected honey-prepared 
methadone proven to contain P. larvae spores. That such 
preparations may be contaminated with spores of this or-
ganism is not well known among pharmacists, physicians, 
and addicts. 
A
s a consequence of needle sharing and repeated par-
enteral administration of nonsterile material, injection 
drug users risk becoming ill from a variety of infections, 
including HIV, hepatitis C, endocarditis, and skin and soft 
tissue infections (1). Febrile episodes in injection drug users 
are common, yet distinguishing between febrile reactions 
caused by toxins or impurities in the injected substance and 
true infections may be difﬁ  cult (2,3). Methadone hydro-
chloride, which is widely used for opioid substitution, can 
be mixed with viscous substances such as syrup to yield 
a solution that is not suitable for misuse through self-in-
jection. Methadone syrup is intended to be taken only as 
an oral medication. Some pharmacies use honey instead of 
syrup to prepare such a solution.
Paenibacillus larvae is a spore-forming gram-positive 
microorganism known for its ability to cause American 
foulbrood, a severe and notiﬁ  able disease of honey bees 
(Apis mellifera) (4) (Figure). P. larvae is endemic to bee 
colonies worldwide. The organism can be cultured from 
<10% of honey samples from Germany but from >90% of 
samples from honeys imported from other countries (5). P. 
larvae spores are highly resilient and can survive in honey 
for years (6,7). We describe P. larvae bacteremia in 5 pa-
tients who had a history of intravenous drug abuse and were 
in a program of opioid substitution that used methadone.
The Study
All patients sought treatment for fever ranging from 
37.8°C to 39.8°C and admitted to continuing to inject illicit 
drugs or methadone. Information about patient character-
istics, clinical signs and symptoms, laboratory and mico-
biologic investigations, and treatment details are summa-
rized in the Table. P. larvae was identiﬁ  ed in blood cultures 
(BacT/ALERT 3D-System; bioMérieux, Marcy l’Etoile, 
France) of each patient described. The clinical course of 
P. larvae bacteremia was benign in 3 patients, and com-
plications developed in 2 patients. Patient 1 had relapsing 
disease and spontaneous bacterial peritonitis; patient 4 had 
pulmonary embolism without deﬁ   nite evidence of sep-
tic embolism. Patients 2 and 3 recovered without speciﬁ  c 
antimicrobial drug treatment; for patients 4 and 5, defer-
vescence and negative follow-up blood cultures were ob-
served after they received treatment with β-lactam agents 
(imipenem or cefuroxime). The recurrent P. larvae infec-
tion observed in patient 1 was probably the consequence of 
repeated injection of contaminated methadone rather than 
an inadequate response to antimicrobial drug therapy.
In 2 cases, culture of the honey used to prepare metha-
done or of honey-containing ready-to-use methadone also 
yielded P. larvae. Honey and methadone samples were di-
luted in sterile phosphate-buffered saline and cultured with 
or without heat pretreatment (90°C, 10 min) under aerobic 
and anaerobic conditions at 37°C for 3–4 days by using 
Columbia blood agar and MYPGD (Mueller-Hinton broth, 
yeast extract, potassium phosphate, glucose, pyruvate) 
agar. Colonies from positive blood or honey or methadone 
cultures with an appropriate macroscopic appearance and 
gram-stain morphology as well as negative catalase reac-
tion were further identiﬁ  ed by PCR ampliﬁ  cation and 16S 
rRNA gene sequencing according to published protocols 
(8). Obtained sequences were analyzed by using the BLAST 
algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Conclusions
We detected P. larvae in sterile compartments of 5 
patients with clinical and laboratory evidence of infection. 
Given the fact that all patients were injection drug users, 
the mode of infection was thought to be intravenous admin-
istration of contaminated methadone, resulting in P. larvae 
bacteremia. Our hypothesis is supported by the isolation 
of P. larvae from honey or honey-containing methadone 
provided to 2 patients.
Recently, several Paenibacillus species have been re-
ported to cause bacteremic infections in humans. Among 
these are P. thiaminolyticus (bacteremia in a patient under-
going hemodialysis) (9), P. konsidensis (bacteremia in a 
febrile patient with hematemesis) (10), P. alvei (prosthetic 
joint infection with bacteremia) (11), and P. polymyxa (bac-
teremia in a patient with cerebral infarction) (12). Further-
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P. timonensis were isolated from blood cultures of patients 
with carcinoma, interstitial nephropathy, and leukemia, 
respectively (13). Pseudobacteremia of P. hongkongensis 
and P. macerans has been reported (14,15). 
Several aspects provide strong evidence for a genu-
ine P. larvae bacteremia in the cases described here. First, 
the present cases were observed over a period of several 
years, and detection of P. larvae thus occurred in differ-
ent charges of blood culture bottles, which argues against 
pseudobacteremia. Second, isolation of P. larvae was 
reported independently by 2 microbiology laboratories, 
making contamination highly unlikely. Third, in patient 1 
isolation succeeded at different times and in samples of dif-
ferent compartments. Moreover, the detection of P. larvae 
in honey-prepared methadone and honey strongly suggests 
genuine bacteremia as a consequence of injection of con-
taminated material.
Biochemical and molecular identiﬁ  cation of P. larvae 
may be difﬁ  cult and time-consuming. Misinterpretation of 
blood culture results because of incomplete differentiation 
or confusion with other gram-positive spore forming-bac-
teria (e.g., Bacillus species) has to be taken into consider-
ation. Underestimation of the frequency of true P. larvae 
bacteremia therefore cannot be excluded. Thus, infectious 
disease physicians, microbiologists, and pharmacists need 
to be aware that injection of material contaminated with 
P. larvae, such as honey-prepared methadone, may cause 
bacteremic infection. 
Dr Rieg is an infectious diseases fellow at the University 
Medical Center in Freiburg, Germany. His research interests fo-
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Figure. Paenibacillus larvae gram-positive, spore-forming, rod-shaped bacteria (A) (Gram stain, original magniﬁ  cation ×1,000) with the 
ability to form giant whips upon sporulation (B) (nigrosine stain, original magniﬁ  cation ×1,000). In American foulbrood (AFB), newly hatched 
honey bee larvae become infected through ingestion of brood honey containing P. larvae spores. After germination and multiplication, 
infected bee larvae die within a few days and are decomposed to a ropy mass, which releases millions of infective spores after desiccation. 
C) AFB-diseased larvae are beige or brown in color and have diminished segmentation (healthy and AFB-diseased larvae). D) Clinical 
diagnosis of AFB can be made by a matchstick test, demonstrating the viscous, glue-like larval remains adhering to the cell wall.P. larvae Bacteremia 
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Table. Patient characteristics, clinical presentation, treatment, and laboratory and microbiologic results of 5 patients with Paenibacillus
larvae bacteremia* 
Patient no. 
Characteristic 12 3 4 5
Age, y/sex  28/F 32/M 20/M 35/M 27/F
Date evaluated  2003 Jul  2003 Sep  2003 Oct  2004 Feb  2008 May 
Clinical samples with 
identification of P. larvae†
Culture of ascites 
(2003 Jul), blood 
culture (2003 Aug)
Blood culture  Blood culture  Blood culture  Blood culture 
CRP, mg/L 43 17 11 37 40
Leukocyte count, × 10
9/L 23.0 13.0 9.3 11.8 19.2
Medical history IVDA, hepatitis C, 
Child B liver cirrhosis 
with refractory ascites
IVDA, hepatitis C, 
hepatitis B
IVDA, hepatitis 
C
IVDA, hepatitis C, 
history of hepatitis 
A
IVDA, hepatitis C, 
alcohol abuse
Clinical signs and 
symptoms
Decompensated liver 
cirrhosis, ascites, 
fever (39.2°C)
Persistent
weakness and 
malaise, fever 
(39.2°C)
Somnolence,
fever (38.2°C)
Tachypnoe, right-
sided pleuritic chest 
pain, fever (37.8°C)
Severe anemia, 
spontaneous
mucosal bleeding, 
fever (39.8°C)
Clinical conditions other 
than bacteremia
Bacterial peritonitis, 
hepatic
encephalopathy after 
TIPS placement
Acute hepatitis B 
diagnosed 1 mo 
before bacteremia, 
eosinophilia
Methadone/
diazepam
overdose
Pulmonary 
embolism, infarction 
pneumonia, deep 
vein thrombosis
Subsequently 
diagnosed with ITP,
Paracoccus yeei
and Micrococcus 
luteus bacteremia
Treatment (duration) Meropenem (7 d) 
followed by ampicillin 
IV (2 d), then 
meropenem (7 d) 
followed by penicillin 
G (14 d)
None None Cefuroxim IV (7 d) Imipenem (21 d)
*CRP, C-reactive protein (reference range <5 mg/L); IVDA, intravenous drug abuse; TIPS, transjugular intrahepatic portosystemic shunt; ITP, idiopathic 
thrombocytopenic purpura; IV, intravenous.  
†P. larvae identified after culture using 16S rRNA gene sequencing.  
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